InSilico Medicine (英矽智能) IPO Trading
InSilico Medicine raises $261m in global offering, set to list on Hong Kong Stock Exchange on December 30th. We provide an update before trading...
668 Views
Pre-IPO InSilico Medicine - Thoughts on Valuation, Peer Comparison and Forecast
Insilico's IPO debut not only reflects the positive market sentiment but also demonstrates the recognition of its business model. As analyzed,...
1k Views
Insilico Medicine IPO: Shortening Drug Discovery Period Through AI-Driven Platform Holds Promise
Insilico Medicine plans to raise $292M through HK listing. The company is offering 94M shares priced at HK$24.05 per share. The IPO is scheduled to...
1k Views
InSilico Medicine (英矽智能) IPO: AI Assets as Upside
InSilico Medicine launches IPO in Hong Kong to raise $293 million, with valuation anchored by innovative assets and potential upside from AI...
968 Views
Primer: InSilico Medicine Cayman TopCo (ISM HK) - Dec 2025
InSilico Medicine is a clinical-stage biotechnology company leveraging a proprietary end-to-end generative AI platform, Pharma.AI, to accelerate...
206 Views